Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Barrowcliffe

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Thrombosis and Haemostasis|April 8, 1991
Experimental studies on a recombinant hirudin, CGP 39393E Gray, J Watton, S Cesmeli, et al.
British Journal of Haematology|June 1, 1993
The behaviour of different factor VIII concentrates in a chromogenic factor X-activating systemG Kemball-Cook, J E Tubbs, N J Dawson, et al.
Thrombosis and Haemostasis|November 1, 1996
In vivo studies of activated porcine factor VIIIJ D Littlewood, S A Bevan, G Kemball-Cook, et al.
Biochimica Et Biophysica Acta|May 29, 1998
Structural determination of lipid-bound human blood coagulation factor IXS Stoylova, E Gray, T W Barrowcliffe, et al.
Thrombosis and Haemostasis|June 30, 1981
Studies in man and experimental animals of a low molecular weight heparin fractionD P Thomas, R E Merton, W E Lewis, et al.
Thrombosis and Haemostasis|August 30, 1988
An international standard for low molecular weight heparinT W Barrowcliffe, A D Curtis, E A Johnson, et al.
Thrombosis and Haemostasis|May 24, 2000
New recombinant standard for FVIII concentrate gives same results as previous plasma derived standards on a range of FVIII productsM E Albertengo, T W Barrowcliffe, L Oliva, et al.
Thrombosis Research|November 15, 1981
In vitro and in vivo studies of the anti-Xa activity of heparinC A Eggleton, T W Barrowcliffe, R E Merton, et al.
Journal of Thrombosis and Haemostasis : JTH|January 7, 2005
A collaborative study to establish the 7th International Standard for Factor VIII ConcentrateS Raut, S Bevan, A R Hubbard, et al.
The Journal of Biological Chemistry|November 25, 1994
Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharideB Mille, J Watton, T W Barrowcliffe, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Thrombosis and Haemostasis|April 8, 1991
Experimental studies on a recombinant hirudin, CGP 39393E Gray, J Watton, S Cesmeli, et al.
British Journal of Haematology|June 1, 1993
The behaviour of different factor VIII concentrates in a chromogenic factor X-activating systemG Kemball-Cook, J E Tubbs, N J Dawson, et al.
Thrombosis and Haemostasis|November 1, 1996
In vivo studies of activated porcine factor VIIIJ D Littlewood, S A Bevan, G Kemball-Cook, et al.
Biochimica Et Biophysica Acta|May 29, 1998
Structural determination of lipid-bound human blood coagulation factor IXS Stoylova, E Gray, T W Barrowcliffe, et al.
Thrombosis and Haemostasis|June 30, 1981
Studies in man and experimental animals of a low molecular weight heparin fractionD P Thomas, R E Merton, W E Lewis, et al.
Thrombosis and Haemostasis|August 30, 1988
An international standard for low molecular weight heparinT W Barrowcliffe, A D Curtis, E A Johnson, et al.
Thrombosis and Haemostasis|May 24, 2000
New recombinant standard for FVIII concentrate gives same results as previous plasma derived standards on a range of FVIII productsM E Albertengo, T W Barrowcliffe, L Oliva, et al.
Thrombosis Research|November 15, 1981
In vitro and in vivo studies of the anti-Xa activity of heparinC A Eggleton, T W Barrowcliffe, R E Merton, et al.
Journal of Thrombosis and Haemostasis : JTH|January 7, 2005
A collaborative study to establish the 7th International Standard for Factor VIII ConcentrateS Raut, S Bevan, A R Hubbard, et al.
The Journal of Biological Chemistry|November 25, 1994
Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharideB Mille, J Watton, T W Barrowcliffe, et al.
Pageof 16